These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 10349065)
21. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
22. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003. Cowden AL; Katz KA Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900 [TBL] [Abstract][Full Text] [Related]
23. The educational value of consumer-targeted prescription drug print advertising. Bell RA; Wilkes MS; Kravitz RL J Fam Pract; 2000 Dec; 49(12):1092-8. PubMed ID: 11132058 [TBL] [Abstract][Full Text] [Related]
24. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements. Hall DV; Jones SC Aust N Z J Public Health; 2008 Oct; 32(5):471-8. PubMed ID: 18959553 [TBL] [Abstract][Full Text] [Related]
25. Differences in the volume of pharmaceutical advertisements between print general medical journals. Gettings J; O'Neill B; Chokshi DA; Colbert JA; Gill P; Lebovic G; Lexchin J; Persaud N PLoS One; 2014; 9(1):e84790. PubMed ID: 24416286 [TBL] [Abstract][Full Text] [Related]
26. Perpetuating stigma? Differences between advertisements for psychiatric and non-psychiatric medication in two professional journals. Foster JL J Ment Health; 2010 Feb; 19(1):26-33. PubMed ID: 20380495 [TBL] [Abstract][Full Text] [Related]
27. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
28. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Robinson AR; Hohmann KB; Rifkin JI; Topp D; Gilroy CM; Pickard JA; Anderson RJ Arch Intern Med; 2004 Feb; 164(4):427-32. PubMed ID: 14980994 [TBL] [Abstract][Full Text] [Related]
29. Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses. Bell RA; Wilkes MS; Kravitz RL J Fam Pract; 1999 Jun; 48(6):446-52. PubMed ID: 10386488 [TBL] [Abstract][Full Text] [Related]
30. Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat. Gensini GF; Conti AA Ital Heart J; 2003 Feb; 4(2):80-3. PubMed ID: 12762269 [TBL] [Abstract][Full Text] [Related]
31. Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study. Diep D; Mosleh-Shirazi A; Lexchin J BMJ Open; 2020 Jul; 10(7):e034993. PubMed ID: 32690502 [TBL] [Abstract][Full Text] [Related]
32. Quality of claims and references found in Australian pharmacy journal advertisements. Mandoh M; Curtain CM Int J Pharm Pract; 2017 Oct; 25(5):365-370. PubMed ID: 27896882 [TBL] [Abstract][Full Text] [Related]
33. Direct-to-consumer advertising and the patient-physician relationship. Shah MB; Bentley JP; McCaffrey DJ; Kolassa EM Res Social Adm Pharm; 2005 Jun; 1(2):211-30. PubMed ID: 17138475 [TBL] [Abstract][Full Text] [Related]
34. Drug advertisements in Indian medical journals. Lal A; Sharma ML Indian J Physiol Pharmacol; 1992 Apr; 36(2):139-40. PubMed ID: 1506082 [No Abstract] [Full Text] [Related]
35. [Are drug advertisements of any informative value? Analysis of drug advertisements in the Swedish Medical Journal (LÀkartidningen) and the Norwegian Medical Journal (Tidsskrift for Den norske laegeforening) during the first half of 1986]. StÄlsby C; Westerholm B Tidsskr Nor Laegeforen; 1987 Jun; 107(17-18):1573-7. PubMed ID: 3603531 [No Abstract] [Full Text] [Related]
36. Mixed messages on tobacco: comparative exposure to public health, tobacco company- and pharmaceutical company-sponsored tobacco-related television campaigns in the United States, 1999-2003. Wakefield M; Szczypka G; Terry-McElrath Y; Emery S; Flay B; Chaloupka F; Saffer H Addiction; 2005 Dec; 100(12):1875-83. PubMed ID: 16367989 [TBL] [Abstract][Full Text] [Related]
37. Relationship between drug company funding and outcomes of clinical psychiatric research. Kelly RE; Cohen LJ; Semple RJ; Bialer P; Lau A; Bodenheimer A; Neustadter E; Barenboim A; Galynker II Psychol Med; 2006 Nov; 36(11):1647-56. PubMed ID: 16893480 [TBL] [Abstract][Full Text] [Related]
38. Claims in advertisements for antihypertensive drugs in a Dutch medical journal. Greving JP; Denig P; de Zeeuw D; Haaijer-Ruskamp FM J Hypertens; 2007 Mar; 25(3):713-22. PubMed ID: 17278989 [TBL] [Abstract][Full Text] [Related]
39. [Profile of biostatistics utilization in three medical reviews. Implications for medical education]. Gagnon RJ; Marchand R; Marcil M Can Fam Physician; 1996 May; 42():888-94. PubMed ID: 8688692 [TBL] [Abstract][Full Text] [Related]
40. [NNT--numbers needed to treat]. Netzer D; Berkovitzs E; Reis S; Weinberger T Harefuah; 2003 Jul; 142(7):541-3, 565. PubMed ID: 12908391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]